繁體中文
Deutsch
Español
Français
Italiano
Polski
Português
Română
Русский

幹細胞治療腦癱3個月後的驚人結果

⏲️1分钟阅读
Ava在理療過程中

2022年2月,Ava和她的媽媽來到泰國。 經過23天的治療後,他們回到瑞士,非常有信心情況會很快好轉。 3個月後,Ava的媽媽聯系了我們,分享了關於她女兒的所有好消息,以下是她自己的話

如果我們能設法盡快再次去泰國接受第二次治療,我們會很高興。

病史

Ava has periventricular leukomalacia and this has resulted in Tetra Cerebral Palsy; Ava is also severely visually impaired. Ava cannot manage her daily life without us, she is dependent on assistance 24 hours a day. She has no control over her trunk or head and is subject to severe spasticity.

治療

Ava has a healthy twin sister, so the thought of using stem cells to treat her occurred to me. In Switzerland and Europe, this treatment is not allowed, so we found Beike and spent a year getting well informed about the treatment and what risks it can bring for Ava. Our doctors are all very skeptical about this treatment. We always figured if it didn’t help Ava, it would be an expensive rehabilitation treatment.

我們在網上發現了北科 我們非常了解泰國,我們非常欣賞他們的心態。 這是我們更準確地通知我們的一個因素。
我們希望我們的女兒會更加獨立,她會找到一種溝通和決定自己的方式。

治療

由於我們是在科羅納重新開放後不久到達的,我們仍然不得不接受隔離。

We were comfortable at all times but often misunderstood as well. All our concerns were promptly addressed and we are thankful for that. Thais therapists are all amazing! Professional and knowledgeable. Especially physiotherapy or occupational therapy. All are very accommodating and supportive.

治療後

一個月後,在泰國的最後一周,我已經感受到並看到了Ava的第一次變化,但在我看來,這是強化治療,因為細胞仍在尋找進入Ava大腦的途徑。 回到家後,我們不幸被感染COVID-19。 她的癥狀是中耳感染和高燒。 這些都是她治療後不該有的,但最終,這並沒有影響她的成功。

現在治療已經4個月了,Ava已經變成另一個女孩,難以置信!!!

當然值得一提的是,她每周接受四次治療,我們作為一個家庭,每天都非常緊張地與她一起工作。 我們希望在幹細胞移植後的3到6個月的黃金期達到最大效果。

我們可以和她交流,她舉起右臂表示一切:是的,更多,積極,你好。 認知上的巨大進步。

她有更好的軀幹和頭部控製,她的痙攣不再明顯。 她可以坐在她的治療椅上(不是獨立的),但她的上身不再前傾。 由於她的頭部位置更好,Ava可以吃得更好(沒有更快)。

她也已經接受了6周的強化康復治療,並發展了很好的溝通技巧。 以至於我們現在甚至開始使用計算機程序來幫助她交流。

Ava正在變得更加獨立,能夠交流,所以她不再獨自生活在她的世界裏——每天都很高興看到這一點。

如果我們能設法盡快再次去泰國接受第二次治療,我們會非常高興!!!

要了解Ava的進展,請點擊此處進入她的臉書

引用

  1. Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats
  2. Umbilical cord blood cells and brain stroke injury: bringing in fresh blood to address an old problem
  3. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains
  4. Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum
  5. Li Huang, Che Zhang et al (2018). A Randomized, Placebo-Controlled Trial of Human Umbilical Cord Blood Mesenchymal Stem Cell Infusion for Children With Cerebral Palsy. Cell Transplantation (2018) Vol. 27(2) 325-334
  6. F. Ramirez, ET AL. Umbilical Cord Stem Cell Therapy for Cerebral Palsy. Med Hypotheses RES 2006.3: 679-686.
  7. James E Carroll & Robert W Mays. Update on stem cell therapy for cerebral palsy. Expert Opin. Biol. Ther. (2011) 11.
  8. David T. Harris. Cord Blood Stem Cells: A Review of Potential Neurological Applications. Stem Cell Rev (2008) 4:269–274.